Surgepays is trading at $0.13, down -5.57%, with no clear company-specific explanation for the October 12 decline in available coverage.
- Nasdaq lists a 424B5 filing dated October 9, but its presence alone does not establish it as the cause.
- Major indexes were mixed and little changed; broader-market sentiment does not clearly explain the decline.
- Trading volume was not confirmed by a reliable source.